Target intelligence / Profile preview

Class D β-lactamase (OXA-type) (OXA β-lactamase)

Target
OXA β-lactamase
Molecular classification
Enzyme, Serine hydrolase, β-lactamase (class D)
01

Overview

OXA β-lactamases are a family of class D serine-based enzymes, conventionally named for their oxacillinase activity, that hydrolyze and inactivate β-lactam antibiotics such as penicillins, cephalosporins, and carbapenems. They are widely distributed among Gram-negative bacteria, often encoded by transferable plasmids as well as chromosomes, notably in ESKAPE pathogens. These enzymes are poorly inhibited by many standard β-lactamase inhibitors, with over 750 known variants conferring potentially both narrow- and extended-spectrum resistance. Some lipidated OXA β-lactamases, particularly in Acinetobacter spp., localize to the membrane and play significant roles in high-level antibiotic resistance. Their substrate specificity and catalytic mechanisms are structurally distinguished by a conserved Ser-x-x-Lys motif and a carboxylated lysine in the active site, making them challenging therapeutic targets in multidrug-resistant infections[1][2][3][4][5]. If specificity for a single variant is needed (e.g., OXA-23), more detailed names and function can be given, but "OXA β-lactamase" covers the therapeutically relevant class D β-lactamase enzymes responsible for much of current β-lactam resistance.

Other names
OXA-type β-lactamaseoxacillinaseclass D β-lactamaseOXA enzyme
02

Mechanism of action

Drug hydrolysis (breaking the β-lactam ring, rendering antibiotics inactive); Confers resistance by enzymatically inactivating β-lactam antibiotics[3][4]

03

Biological functions

Antibiotic resistanceHydrolysis of β-lactam antibiotics
04

Disease associations

Infection (notably hospital-acquired and multidrug-resistant infections)Other (primary mechanism in antibiotic resistance for Gram-negative pathogens)
05

Safety considerations

Multidrug-resistant bacterial infectionsTherapeutic limitations due to broad antibiotic resistanceDifficulties in detecting and treating OXA-mediated resistance, especially in Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa, and other ESKAPE pathogens[3][5]
06

Interacting drugs

β-lactam antibiotics (penicillins, cephalosporins, carbapenems)

1 more in the full profile.

07

Biomarkers

Detection of OXA β-lactamase genes in bacterial isolates (e.g., PCR for OXA-23, OXA-48, OXA-51-like variants)[2]Elevated minimum inhibitory concentrations (MICs) for β-lactam antibiotics in clinical microbiology

Beyond the preview

Go deeper on Class D β-lactamase (OXA-type) (OXA β-lactamase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Class D β-lactamase (OXA-type) (OXA β-lactamase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call